TOENAIL FUNGUS TREATMENT Liquid Dailymed
Generic: tolnaftate, undecylenic acid
Go PRO for all pill images
TOENAIL FUNGUS TREATMENT Liquid
Otc - Active Ingredient Section
TOLNAFTATE 1% UNDECYLENIC ACID 25%
Otc - Purpose Section
Anti-fungal
Indications & Usage Section
For the effective treatment of nail fungus, discoloration, thickeningsplitting,crumbling and brittleness.
Warnings Section
For external use only.
Otc - Do Not Use Section
Children under 2 years of age. pregnant or if there is any allergic reaction to this produce.
Otc - When Using Section
When using this product Avoid contact with eyes
Otc - Stop Use Section
Stop use and ask a doctor if lrritation occurs or discomfort persists.
Otc - Keep Out Of Reach Of Children Section
If product gets into eyes,flush with water for 15 minutes.
If swallowed,get medical help or contact a Poison Control Centerright away.
Dosage & Administration Section
For initial use, soak the affected nail in warm water to soften it.Gently fle thenail to make it thinner and remove dirt, being cautiousnot to harm the nail bed. Apply full layers of nail solution with brush onto affected areas onaround ,and under nails. A light tingle or burn is normal for the frst10 minutes until the product is absorbed into the skin. Apply the product twice a day, in the morning and at night. Visible results will be seen in as little as 6 weeks, continue regularusage to prevent fungus regrowth.
Storage And Handling Section
heat above 40'C(104°) Store between 15° to 30 °C (59°to 86 ℉ )Avoid freezing and excessive
Inactive Ingredient Section
ALCOHOL DIMETHICONE CETOSTEARYL ALCOHOL TEA TREE OIL PROPYLENE GLYCOL TOCOPHEROL SAFFLOWER OIL WATER
Package Label.principal Display Panel
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site